Only a few months into their race to get the entire world injected with their COVID-19 shots, Pfizer and Moderna have decided to hike the prices of their experimental gene therapies.
When the treatments first gained emergency use authorization to deliver to millions of people as “vaccines” without having cleared the normal hurdles of bringing a vaccine to market, both Moderna and Pfizer promised that profits were not their goal. But now, as governments contemplate mandating the shots in their respective countries, as well as expanding its delivery with booster shots and also offering it to children, Pfizer’s charge to governments is going up by 25%; Moderna’s is spiking by 10%.
Their excuse for the sudden price increases was that their products are more valuable than competing ones popping up on the market. But, as ZeroHedge succinctly put it, “In reality, Big Pharma is just trying to do right by its shareholders as sales are expected to boom.”
SOURCE: ZeroHedge August 2, 2021